Novartis Probers Finds Says Employees Took Patient Data In Diovan Study
This article was originally published in PharmAsia News
Executive Summary
A panel of investigators formed by Novartis Pharma in Japan has concluded some employees may have violated privacy law and kept and read questionnaire responses of participants in a clinical trial.